Evaluation of Predicted siRNA as an Antiviral against MERS-CoV Targeting the Membrane Gene in the Vero Cell Line

Evaluation of Predicted siRNA as an Antiviral against MERS-CoV Targeting the Membrane Gene in the Vero Cell Line

The Middle East respiratory syndrome coronavirus (MERS-CoV) was first isolated from a patient with acute pneumonia and renal failure in Saudi Arabia in 2012. By July 2023, MERS-CoV had resulted in 2605 human cases worldwide, causing a fatality rate of 36%, with 90.2% of cases being located in the Ar...

Full description

Bibliographic Details
Main Authors: Amany Y. El-Sayed, Mahmoud Shehata, Sara H. Mahmoud, Mahmoud ElHefnawi, Dina M. Seoudi, Mohamed A. Ali
Format: Article
Language:English
Published: MDPI AG 2023-10-01
Series:Microbiology Research
Subjects:
siRNA
MERS-CoV
in silico
in vitro
antiviral
Online Access:https://www.mdpi.com/2036-7481/14/4/116

Similar Items

Similar Items